Agilus Diagnostics to merge wholly-owned subsidiaries

Agilus Diagnostics Limited, a material subsidiary of Fortis Healthcare Ltd, announced today that its Board of Directors has approved an intra-group restructuring. This involves the merger of its wholly-owned subsidiaries, Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs Limited, into Agilus Diagnostics Limited via a Scheme of Arrangement. The merger is subject to approvals from the National Company Law Tribunals (NCLTs) and the companies' members and creditors. As this is an intra-group restructuring, no consideration will be payable.